Кирилл Кошкин - Психопатологическая структура апатической депрессии

126. Andreasen N. C. Symptoms, signs, and diagnosis of schizophrenia // Lancet. 1995. Vol. 346 (8973). P.477–481.

127. Angst J. How recurrent and predictable is depressive illness? // Long-term treatment of depression / S. Montgomery, F. Rouillon (Eds.). NY: John Willey, 1992.P.1–13.

128. Angst J. Aetiologie und Nosology endogener Depressionen. Berlin: Springer-Verlag, 1966.

129. Angst J., Dobler-Mikola A. The Zurich study: A continuum from depression to anxiety disorders? // Eur. Arch. Psychiat. Neurol. Sci. 1985. Vol.235. №.3. P.179–186.

130. Bleuler E. Dementia praecox oder Gruppe der Schizophrenien. Leipzig: Franz Deuticke, 1911.

131. Canadian Psychiatric Association. Clinical Guidelines for the treatment of depressive disorders // Can. J. Psychiatry. 2001. Vol. 46. Suppl. 1. P. 1–90.

132. Carpenter W. T., Heinrichs D. W., Alphs L. D. Treatment of negative symptoms // Schizophr. Bull. 1985. Vol.11 (3). P.440–452.

133. Cassano G. B., Musetti L., Perugi G. et al. A proposed new approach to the clinical subclassification of depressive illness // Pharmacopsychiatry. 1988. Vol. 21 (1). P.19–23.

134. Choi S. H., Na D. L., Kwon H. M. et al. The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients // J. Korean Med. Sci. 2000. Vol.15 (6). P.609–615.

135. Claxton A. J., Li Z., McKendrick J. Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression // Br. J. Psychiatry. 2000. Vol. 177. P. 163–168.

136. Conrad K. The problem of «nosological unity» in psychiatry // Nervenarzt. 1959. Vol.30. P.488–494.

137. Cowen P. J. Pharmacological management of treatment-resistant depression // Adv. Psychiatr. Treatment. 1998. Vol. 4. P. 320–327.

138. Danzon M. Mental health: facing the challenges, building solutions: report from the WHO European Ministerial Conference, 2006.

139. Deniker P. Clinical forms & diagnosis of thymic psychoses; questionnaire // Encephale. 1957. Vol.46 (1). P.19–25.

140. Depont F., Rambelomanana S., Puil S. et al. Antidepressants: psychiatrists’ opinions and clinical practice // Acta Psychiatr. Scand. 2003. Vol. 108. P. 24–31.

141. Derouesne C., Lacomblez L. Depression and dementia // Psychol. Neuropsychiatr. Vieil. 2004. Vol.2. Suppl.1. P.35–42.

142. Desjarlais R., Eisenberg L., Good B. et al. World mental health: problems and priorities in low-income countries. NY: Oxford university press, 1995.

143. Donoghue J. M. Sub-optimal use of tricyclic antidepressants in primary care // Acta Psychiatr. Scand. 1998. Vol. 98. Р. 429–431.

144. Donoghue J. M., Tylee A. The treatment of depression: prescribing patterns of antidepressants in primary care in the UK // Br. J. Psychiatry. 1996. Vol. 168. P. 164–168.

145. Duffy J. Apathy in neurologic disorders // Curr. Psychiatry Rep. 2000. Vol. 2. P.434–439.

146. Ernst E., Gerada C., Hood S., Nutt D. A depressed man requesting St John’s wort // Practitioner. 1999. Vol.243 (1604). P.779–782.

147. Ey H. Etudes Psychiatriques. Desclée de Brouwer t.I, 1948, 296 pages; t. II, 1950, 550 p.; t. III, 1954. Réédité en 2 volumes et un CDRom, Préface Patrice Belzeaux et Jean Garrabé, éd. CREHEY, Cercle de Recherche et d’Édition Henri Ey, 2007.

148. Falret J. Folie circular // Bull. Acad. Nat. Med. 1853–1854. Vol.19. P. 356.

149. Fava M., Rankin M. A., Wright E. C. et al. Anxiety disorders in major depression // Compr. Psychiatry. 2000. Vol. 41. P. 97–102.

150. Finset A., Andersson S. Coping strategies in patients with acquired brain injury: relationships between coping, apathy, depression and lesion location // Brain Inj. 2000. Vol.14. P.887–905.

151. Furukawa T. A., Kitamara T., Takashishi K. Time to recovery of an inception cohort with hither to untreated unipolar major depressive episodes // Br. J. Psychiatry. – 2000. – Vol. 177. – P. 331–335.

152. Glatzel J. Allgemeine Psychopathologie. Stuttgart: Ferdinand Enke Verlag, 1978.

153. Glatzel J., Huber G. Zur Phanomenologie eines Types endogener juvenil-astenischer Versagensyndrome // Psychiatr. Clin. 1968. № 1. P.13–31.

154. Glozier N. Workplace effects of the stigmatization of depression // J. Occup. Environ. Med. 1998. Vol. 40. P. 793–800.

155. Guse S. B., Robins E. Suicide and primary affective disorders // British Journal of Psychiatry. 1970. Vol. 117. P.437–448.

156. Haddad P. M. Social and economic aspects of depression // WPA Teaching Bull. 1995. Vol. 2. № 8. P. 1–2.

157. Hall R. C. W., Wise M. G. The clinical and financial burden of mood disorders cost and outcome // Psychosomatics. 1995. Vol. 9. P. 195–201.

158. Hamilton M. A rating scale for depression // J. Neural. Neurosurg. Psychiatry. 1960. Vol.23. P. 56–62.

159. Hamilton M. Frequency of symptoms in melancholia (depressive illness) // Br. J. Psychiatry. 1989. Vol.154. P.201–206.

160. Hamilton M. The clinical distinction between anxiety and depression // The borderline between anxiety and depression. Medidact., Leusden, Netherland, 1988. P.11–21.

161. Hirschfeld R. M., Keller M. B., Panico S. et al. The national depressive and manic-depressive association consensus statement on the undertreatment of depression // JAMA. 1997. Vol. 277. P. 333–340.

162. Hirschfeld R. M. WPA. Teaching Bulletin on Depression. 2000. Vol. 4. № 19. P. 7–10.

163. Hotopf M., Lewis G., Normand C. Are SSRIs a cost-effective alternative to tricyclics? // Br. J. Psychiatry. 1996. Vol. 168. P. 404–409.

164. Janzarick K. Problem der strukturell-dynamisschen Koharenz in der Zyklothymieforschung // Hervenarzt. 1974. Bd.45. P.623–638.

165. Judd L. L., Akiskai H. S., Мaser J. D. et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders // Arch. Gen. Psychiatry. 1997. Vol. 55. P. 694–700.

166. Kaplan H., Sadock J. Клиническая психиатрия. М., 1998. C.278–360.

167. Katon W., Von Korff M., Lin E. et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial // Arch. Gen. Psychiatry. 1999. Vol. 56. P. 1109–1115.

168. Katzelnick D. J., Simon G. E., Pearson S. D. et al. Randomized trial of a depression management program in high utilizers of medical care // Arch. Fam. Med. 2000. Vol. 9. P. 345–351.

169. Kessler R. C., McGonagle K. A., Zhao S. et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey // Arch. Gen. Psychiatry. 1994. Vol. 51. P. 8–19.

170. Kessler R. C., Frank R. G. The impact of psychiatric disorders on work loss days // Psychol. Med. 1997. Vol. 27. Р. 861–873.

171. Kielholz P. Psychische krankhut n. Stress // Schweis. Arch. Neurol. Psychiatr. 1977. Bd.121. № 1. P.9–19.

172. Kielholz P. Chronisce endogene Depressionen // Chronische endogene Psychosen / Hrsg. H. von Kranz, K. Heinrich. Stutgart, 1973. S.5–7.

173. Kielholz P. Die Depression in der taglichen Praxis. Bern, 1974.

174. Kind P., Sorensen J. Modeling the cost-effectiveness of the prophylactic use of SSRIs in the treatment of depression // Int. Clin. Psychopharmacol. 1995. Vol. 10. Suppl. 1. P. 41–48.

175. Kind P., Sorensen J. The costs of depression // Int. Clin. Psychopharmacol. 1993. Vol. 7. P. 191–195.

176. Kowacs M., Deinberg T. L., Crouse-Novar M. A. et al. Depressive disorders in childhood // Arch. Gen. Psychiat. 1984. Vol.41. P.223–237.

177. Kraepelin E. Psychiatrie. 8 Aufl Bd. 1–4. Leipzig: Barth, 1909–1915.

178. Kupfer D. J., Frank E. Maintenance therapy for chronic depression // Arch. Gen. Psychiatry. 1996. Vol. 53. P. 775–776.

179. Lader M. H., Wing L. Physiological measures in agitated and retarded depressed patients // J. Psychiatr. Res. 1969. Vol.7 (2). P.89–100.

180. Leonhard K. Aufteilung der Endogenen Psychosen. Berlin, 1957.

181. Lepine L. P., Gastpar M., Mendlewicz J. et al. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society) // Int. Clin. Psychopharmacol. 1997. Vol. 12. P. 19–29.

182. Lesperance F., Frasure-Smith N. Depression in patients with cardiac disease: a practical review // J. Psychosom. Res. 2000. Vol. 48. Р. 379–391.

183. Levy M. L., Cummings J. L., Fairbanks L. A. et al. Apathy is not depression // J. Neuropsychiatry Clin. Neurosci. 1998. Vol.10 (3). P.314–319.

184. MacDonald T. M., Reid I. C., McMahon A. D. Patients receive an inadequate dose of antidepressants for an inadequate period // Br. Med. J. 1997. Vol. 315. P. 56–58.

185. Marin R. S. Differential diagnosis and classification of apathy // Am. J. Psychiatry. 1990. Vol.147 (1). P.22–30.

186. Marin R. S, Butters M. A., Mulsant B. H. et al. Apathy and executive function in depressed elderly // J. Geriatr. Psychiatry Neurol. 2003. Vol.16 (2). P.112–116.

187. Marin R. S., Firinciogullari S., Biedrzycki R. C. The sources of convergence between measures of apathy and depression // J. Affect. Disord. 1993. Vol.28 (1). P.7–14.

188. McManus P., Mant A., Mitchell P. et al. Use of antidepressants by general practitioners and psychiatrists in Australia // Austral. N. Z. J. Psychiatry. 2003. Vol. 37. P. 184–189.

189. Menier J., Lfo P. Privative syndrome of brain-injured patients (aboulia, asthenia, apathy, ataraxia) // Ann. Med. Psychol. (Paris).1980. Vol. 138. P.261–275.

190. Montgomery S. A., Kasper S. Comparison of compliance between selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis // Int. Clin. Psychopharmacol. 1995. Vol. 9. Suppl. 4. P. 33–40.

191. Mueller T. I., Leon A. C., Keller M. B. et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up // Am. J. Psychiatry. 1999. Vol. 156. P. 1000–1006.

192. Murray J. L., Lopez A. D. (Eds). The global burden of disease: a comprehensive assessment of morality and disability from disease. Injuries and risk factors in 1990 and projected to 2020 (Summury). WHO, World Bank, Harvard School of Public Health, 1996.

193. Nelson J., Charney D. The symptoms of Major Depressive illness // Am. J. Psychiatr. 1981. Vol.138. № 1. P.1–13.

194. Nuijten M., Hardens M., Souetre E. A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression // Pharmacoеconomics. 1995. Vol. 8. P. 159–168.

195. Okasha A., Kamel M., Khalil A. et al. Academic difficulty among male Egyptian university students. I. Association with psychiatric morbidity // Br. J. Psychiatry. 1985. Vol.146. P.140–144.

196. Oliveira-Souza R. D., Figueiredo W. M. Multimodal iatrogenic apathy // Arq. Neuropsiquiatr. 1996. Vol.54. P.216–221.

197. Ormel J., Von Korff M., Oldehinkel A. J. et al. Onset of disability in depressed and non-depressed primary care patients // Psychol. Med. 1999. Vol. 29. P. 847–853.

198. Ozaki S., Wada K. Amotivational syndrome in organic solvent abusers // Nippon Yakurigaku Zasshi. 2001. Vol. 117. P.42–48.

199. Parikh S. V., Lesage A. D., Kennedy S. H. et al. Depression in Ontario: under-treatment and factors related to antidepressant use // J. Affect. Disord. 1999. Vol. 52. P. 67–76.

200. Payk Th. R. Therapy of depressive psychoses // Ther. Ggw. 1977. Vol.116 (10). P.1816–1826.

201. Paykel E. S., Brugha T., Fryers T. Size and burden of depressive disorders in Europe // Eur. Neuropsychopharm. 2005. Vol. 15. P. 411–423.

202. Picat G. Conduit a tenir devan un etat depressif // Arch. Med. Norm. 1975. Vol.12. P.583–590.